Global Blood Irradiation Market Growth 2025-2031

Global Blood Irradiation Market Growth 2025-2031

The global Blood Irradiation market size is predicted to grow from US$ 68.8 million in 2025 to US$ 117 million in 2031; it is expected to grow at a CAGR of 9.2% from 2025 to 2031.

Irradiation of human blood is used to avoid the TA-GVHD (transfusion-associated graft-versus-host-disease), a rare but devastating adverse effect of leukocytes present in blood component for immunocompetent transfusion recipients. It is worth noting that cesium and X-ray irradiators are devices dedicated to blood irradiation, usually operated by specialized institutions or departments external to the healthcare facilities that are actually using the irradiated blood (and thus have to purchase it from the irradiation service providers); in contrast, many user facilities already have LINACs and cobalt sources for cancer therapy and other treatments. These units, although they are designed for other purposes, can be used for blood irradiation on a limited basis. For example, a blood bag holder can be placed where a patient would be exposed and the LINAC operated to irradiate the blood instead of a person.

The primary drivers of the blood irradiation market is the rising prevalence of immune-compromised conditions, such as cancer, organ transplant, and autoimmune diseases. These conditions often require blood transfusions, where blood irradiation can prevent transfusion-associated graft-versus-host disease (TA-GVHD). Additionally, advancements in blood irradiation technology and increased healthcare spending globally are boosting market demand. Regulatory agencies in many regions have also established strict guidelines to ensure the safety of blood transfusions, promoting the adoption of blood irradiation equipment in hospitals and blood banks.

A significant challenge for the blood irradiation market is the high cost associated with irradiation equipment and maintenance. These expenses can be prohibitive for smaller healthcare facilities and blood banks, limiting adoption in low-resource settings. Another challenge is the growing availability of alternative methods for blood sterilization and immunomodulation, which compete with blood irradiation. Regulatory barriers and the need for extensive training and specialized staff for handling irradiation equipment further add to the cost and operational complexity, impacting market growth, particularly in developing countries.

Global Blood Irradiation key players include Best Theratronics, Hitaci, Gilardoni, Gamma-Service, etc. Global top four manufacturers hold a share about 70%. North America is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent. In terms of product, Gamma-ray Blood Irradiation is the largest segment, with a share over 50%. And in terms of application, the largest application is Blood Bank, followed by Hospital, Research Institutions.

LP Information, Inc. (LPI) ' newest research report, the “Blood Irradiation Industry Forecast” looks at past sales and reviews total world Blood Irradiation sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Irradiation sales for 2025 through 2031. With Blood Irradiation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Irradiation industry.

This Insight Report provides a comprehensive analysis of the global Blood Irradiation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Irradiation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Irradiation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Irradiation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Irradiation.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Irradiation market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
X-ray Blood Irradiation
Gamma-ray Blood Irradiation

Segmentation by Application:
Blood Bank
Hospital
Research Institutions

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Best Theratronics
Hitaci
Gilardoni
Gamma-Service
Cegelec
Rad Source
JL SHEPHERD & ASSOCIATES
Shinva Medical
NPIC
CIF medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Irradiation market?

What factors are driving Blood Irradiation market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood Irradiation market opportunities vary by end market size?

How does Blood Irradiation break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.